Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Hogger I remember the cold brewed coffee days, it always sounded good to me. Did Dell ever get the machine fixed?
Rick
Might as well add mine......
Ten years on an island
One day an Irishman who had been stranded on a deserted island for
over 10 years, saw a speck on the horizon. He thought to himself, it's
certainly not a ship. And, as the speck got closer and closer, he began
to rule out the possibilities of a small boat and even a raft.
Suddenly there emerged from the surf a wet-suited black clad
figure. Putting aside the scuba gear and the top of the wet suit, there
stood a drop-dead gorgeous blonde! The glamorous blonde strode up
to the stunned Irishman and said to him, "Tell me, how long has it been
since you've had a cigarette?"
"Ten years," replied the amazed Irishman.
With that, she reached over and unzipped a waterproofed pocket on
the left sleeve or her wetsuit, and pulled out a fresh pack of cigarettes.
He takes one, lights it, and takes a long drag. "Faith and begorrah," said
the man, "that is so good I'd almost forgotten how great a smoke can be!"
"And how long has it been since you! 've had a drop of good Irish
whiskey?" asked the blonde.
Trembling, the castaway replied, "Ten years."
Hearing that, the blonde reaches over to her right sleeve, unzips
a pocket there and removes a flask and hands it to him. He opened the
flask
and took a long drink. "'Tis nectar of the gods!" stated the Irishman.
"'Tis truly fantastic!"
At this point the gorgeous blonde started to slowly unzip the long
front of her wet suit, right down the middle. She looked at the trembling
man and asked, "And how long has it been since you played around?"
With tears in his eyes, the Irishman fell to his knees and sobbed,
"Sweet Jesus! Don't tell me that you've got golf clubs in there too!"
Save that for the Bruins
For all you mozilla user's check out scott's newsletter http://www.scotsnewsletter.com/best_of/firefox.htm
I have nothing to do with scott but have been a subscriber to his newsletter for a long time.
Rick
Go Red Sox!!!!!
sukycospito care to share why?
I love it when sukycospito gets to googling.
Thanks,
Rick
the quote was "working on getting some stability in the funding for the company"
it's at 42:45
Busy day on the board today!!
Have a good weekend everyone.
Hey tibbcat down .06 at least you got the last part right.
"now that I've stated all this we'll probably drop like a rock today... ;)"
6
Hey specul8...I just get tired of the predictions that don't come true,I don't believe they help anything or anyone. I have been here for a long time,and plan to be here for a long time, so they don't mean much to me. I will be happy to chat with ya at scooby's party,I have enough for the entrance fee. Until then I will just punch the clock and count down. I do really hope you are correct.
27
http://neasia.nikkeibp.com/wcs/leaf?CID=onair/asabt/news/294488
Hyundai to Supply MP3 Car Audio Players to Ford Motor
March 8, 2004 (SEOUL) -- Hyundai Motors Co Ltd announced on March 4 that it won an order to supply MP3 car audio players to Ford Motor Co.
The company said that the order was made through Rockford Corp, a U.S.-based car audio manufacturer.
Hyundai Motors supplied US$70 million worth of MP3 car audio players and DVD players in 2003.
(Maeil Business Newspaper, Korea)
it should be 29 days soon don't you think
Ot: maybe. Rule change pushed back.
shorts get an extension to April 1 ...
Effective Date of Amendments to NASD Rule 3370 (Affirmative Determination Requirements) Extended to April 1, 2004
NASD is delaying the effective date of amendments to Rule 3370 (Prompt Receipt and Delivery of Securities—the "Affirmative Determination" Rule) approved by the SEC in November 2003, until April 1, 2004. The amendments expand the scope of the affirmative determination requirements to include orders received from broker/dealers that are not members of NASD (“non-member broker/dealers”). The effective date of the amendments originally was February 20, 2004. NASD understands that some members need to make significant technological changes to their systems to comply with the new requirements; therefore, NASD is extending the effective date to provide members with additional time to make such changes.
Questions concerning this Notice may be directed to Gary L. Goldsholle, Associate General Counsel, Regulatory Policy and Oversight, NASD, at (202) 728-8104; or Patricia M. Albrecht, Assistant General Counsel, Regulatory Policy and Oversight, NASD, at (202) 728-8026
OT......
Thought for today:
There is more money being spent on breast
implants and Viagra than on Alzheimer's research.
This means that by 2020, there should
be a large elderly population with
perky boobs and huge erections and
absolutely no recollection of what to do
with them.
can we help with this?
Rick
peace_2_all..... Jim Shepherd, http://www.jasmts.com has had your views for a while also,he believes we are still headed for and very close to a major crash and a deflationary environment. Not pushing his site, I have been a subscriber and his incites into the market are amazing.
Rick
OT. my sister was at that game, I wonder if she has thawed out yet.
By: suky_cospito
27 Dec 2003, 11:32 AM EST
Msg. 12494 of 12495
Jump to msg. #
Found while googling:
The Frankfurt Stock Exchange is the world's third largest organized exchange-trading market in terms of turnover and dealings in securities. It accounts for more than 85 percent of the total securities turnover in Germany and is the largest of the eight German stock exchanges. It ranks third in the world behind NYSE and NASDAQ markets. Since the launch of XETRA it has offered its clients not only floor trading through brokers but also fully-electronic trading facilities, whereby orders from any point in the globe are automatically inputted into the order book on the central computer.
The Berlin Stock Exchange has recently joined forces with the NASDAQ Europe and has the largest market for offshore securities in the world. The Berlin Unofficial Regulated Market lists over 10,000 international securities from over 60 countries. This unique variety gives the Berlin Stock Exchange an unrivaled position -- not only in Germany, but also in the international area.
.....
Frankfurt is Germany's leading stock exchange, with a total annual volume in excess of almost 4 Trillion USD. In today's markets, the Frankfurt Stock Exchange has consolidated its position as the world's third largest securities trading center organized as a stock market.
One of Frankfurt Stock Exchange's core competences is developing markets and market segments tailored specifically to the needs of particular types of corporation. In addition to the three statutory market segments - first-segment, second-segment and regulated unofficial market - it has also set up an independent segments organised under private law: DAX, MDAX, SMAX and Neuer Markt. U.S. stocks are traded in the "Xetra US Stars" quality segment. All these segments entail stringent corporate transparency requirements
Inclusion in an index such as DAX or MDAX depends on a corporation meeting special requirements in terms of market capitalisation and trading volume on the exchanges.
In SMAX, Deutsche Börse has created a quality segment geared to the specific needs of smaller listed companies, from industry sectors typically the domain of mid-sized businesses Neuer Markt is geared to young companies offering innovative products and a pronounced risk/return profile. It is an independent trading segment with especially strict disclosure and liquidity standards.
.......
In it's basic structure, the Berlin Stock Exchange - with the three market segments Official Trading, Regulated Market, and Over-the-counter Market - does not differ from the other German stock exchanges. In Berlin, however, the OTC market has gained a special degree of relevance. Here, by implementing flexible legal regulations the legislator has enabled the exchange to present itself with a characteristic profile. The Berlin Stock Exchange has seized hold of this opportunity and in recent years has created a unique offer of international securities for the investor in this market segment:
The Berlin OTC market lists the shares of the most important and interesting companies of the world - among them surely some that will move the exchange world in the future, too. Over 10,000 international securities - shares from over 60 countries - can be traded in Berlin. This unique variety gives the Berlin Stock Exchange an unrivaled position - not only in Germany, but in the international area, too: nowhere else do investors have a larger selection of international securities to choose from than in Berlin.
The main pillar of the range of stocks on offer in Berlin are the roughly 6,000 American securities, with every important American company being listed on the Berlin Stock Exchange list. The unique feature here is the range of growth stocks: as the only stock exchange apart from the NASDAQ itself, since August 1999 the Berlin Stock Exchange offers the complete range of the American NASDAQ growth exchange.
By concentrating of the OTC market, the Berlin Stock Exchange has gone one important step towards fulfilling the wishes of the private investors, one that has been very well received. New trading hours from 9.00 am through to 8.00 pm CET enable the informed investor to react even more directly and swiftly to events at foreign stock exchanges.
The innovativeness in particular of the Berlin OTC marketplace and an appropriate emphasis on foreign growth stocks, young technology-oriented German companies, and also eastern European securities attract market participants from all over the world. The number of banks and financial institutes with licenses for the Berlin Stock Exchange has increased almost threefold, from 38 in 1993 to the current figure of 109. The number of authorized independent brokers has also risen. While there are four stockbrokers or stockbroking companies who take care of the official trading, a total of 34 independent brokers and broker companies attend to the regulated market and the OTC market.
.........
(Voluntary Disclosure: Position- Long; ST Rating- Strong Buy; LT Rating- Strong Buy)
holycow I wish I had more money
someone is quietly buying chunks
I wonder who. I wonder why. I wish I was so smart.
Press Release Source: CytoGenix Inc.
CytoGenix Announces Research Agreement with University of Texas Health Science Center Houston for Pre-Clinical Testing of a Gene-Silencing Anti-Bacterial Agent Against Sepsis
Monday December 15, 9:45 am ET
HOUSTON--(BUSINESS WIRE)--Dec. 15, 2003--CytoGenix Inc. (OTCBB:CYGX - News) announced Monday that it has entered into an agreement with the University of Texas Health Science Center Houston Medical School for animal studies using the company's proprietary ssDNA technology against a gene that, when silenced, inhibits bacterial reproduction.
Dr. Jeffrey K. Actor, associate professor, department of pathology and laboratory medicine, will conduct these proof-of-concept studies to determine the effect of this technology on bacterial sepsis induced in mice.
Sepsis is a life-threatening syndrome resulting from bacterial or fungal infection of the blood that can occur after trauma or surgery. Cases of sepsis have risen dramatically in the last twenty years from 164,000 in 1979 to more than 750,000 in 2002; about 215,000 Americans die annually from severe sepsis. Traditional antibiotic therapy has become ineffective because the sepsis-causing pathogens have mutated and developed defenses against all but the most powerful and expensive treatments. Care of people with sepsis costs about $50,000 per case, resulting in an economic burden of nearly $17 billion a year.
"This can be a very significant development in the fight against infectious diseases," stated Dr. Actor. "Sepsis is a very complex condition that acts very quickly, especially against immune-compromised or otherwise weakened individuals. Any improvement in treatment options will be a very important medical development," adds Dr. Actor.
"We have chosen sepsis as the first application of our anti-bacterial because it is a life-threatening condition and a significant economic burden to society; the results of these early trials can lead to the development of a very important therapeutic product," states Dr. Malcolm Skolnick, CytoGenix chairman and CEO.
CytoGenix Inc. is a biopharmaceutical company that develops and markets innovative products and services based on its proprietary DNA expression technology. CytoGenix has products in pre-clinical development, including anti-herpes, anti-psoriasis and anti-inflammatory topical creams. The company owns a US patent for its core DNA expression technology and has 40 international or US pending patent applications.
SAFE HARBOR: Except for statements of historical fact, the statements in this press release are forward-looking. Such statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from the statements made. These factors include, but are not limited to, general economic conditions, risks associated with the acceptance of new products, competition, and other factors more fully detailed in the company's filings with the Securities and Exchange Commission. Additional information about CytoGenix and its technology is found on the Web site at www.cytogenix.com.
--------------------------------------------------------------------------------
Contact:
CytoGenix Inc., Houston
Juan Ferreira, 407-774-9949
--------------------------------------------------------------------------------
Source: CytoGenix Inc.
test
By: steve_robbens
13 Dec 2003, 04:47 PM EST
Msg. 12431 of 12431
Jump to msg. #
Healthcare October 9, 2003
Biotechnology
CytoGenix, Inc. (CYGX-OTC)
“People should not invest in our company unless they have the intent to put some effort into understanding our technology, and then they should follow the way we are developing scientifically. I think if people do that, they will recognize that we have an enormously broad platform that is approachable. We have a business model that we think is beginning to work. We have been in business with this technology for about four years, which is a short time for most Biotechs. We think that in our next round of funding we will get enough money to get a couple of our formulations into clinical trials. If we do, we will see success in our licensing to larger corporations that will be able to take us the rest of the way through the FDA. I advise people to look at our track-record, and look at our future plans to see whether we keep our promises.” - Dr. Malcolm Skolnick
http://www.ceocfointerviews.com/archived_CEO.htm
objective discussion....I don't think so
Dogdog + cygxup = Buy
Kv Mechanical
70 Tolland St, East Hartford, CT 06108
(860) 528-9187
(860) 528-7814 (fax)
Roland L. Violette.........................................
70 Tolland St.
East Hartford, Connecticut 06108 8,886,420 9.2%
I knew that name was familiar, I have worked with KV Mechanical in the past, need to dig into this further. Roland is the owner of KV Mechanical, They do Heating and Air conditioning.
not much on Roland l Violette from google
I'll have to stop by and ring his bell.
Rick
2500 @.60
Press Release Source: CytoGenix Inc.
CytoGenix Announces the Addition of a Preeminent Scientist to Its Scientific Advisory Board
Monday November 24, 9:45 am ET
HOUSTON--(BUSINESS WIRE)--Nov. 24, 2003--CytoGenix Inc. (OTCBB:CYGX - News) announced Monday that Dr. Samuel Kaplan, Professor and Chairman of the Department of Microbiology of the University of Texas Houston Medical School, has joined the CytoGenix Scientific Advisory Board.
Dr. Kaplan's scientific and academic career spans four decades and several continents. He is chairman of the publications board of the American Society of Microbiology, publishers of eleven of the world's premier biological sciences journals. Recognized by his peers, he is the recipient of twelve honorary awards. He has authored over 200 scientific papers and written several chapters of electronic educational texts.
For the past twenty years, Dr. Kaplan has led the investigation of the bacterium Rhodobacter sphaeroides: "This group of bacteria are among the most metabolically diverse organisms known, being capable of growing in a wide variety of growth conditions." Dr. Kaplan is a collaborator in the U.S. Department of Energy-funded R. sphaeroides Genome Project. R. sphaeroides has interesting properties; for example, it can break down or "eat" heavy metals. The scientific knowledge gained in this effort has great implications in the fields of energy transformation and bioremediation.
Dr. Kaplan earned his bachelor's degree from Cornell University, his masters from Yale and his doctorate in molecular genetics from the University of California San Diego. He completed two years of post-doctoral training at Cambridge University. He joined the faculty of University of Illinois - Urbana in 1967 and moved through the institution's academic ranks to the position of professor and director of the Biotechnology Center in 1987. In 1989, he was appointed Chairman of the Department of Microbiology at University of Texas Houston Medical School.
Dr. Kaplan stated, "I am always excited by the prospects of applying molecular genetics to real world problems. CytoGenix is making considerable progress in using its single strand DNA technology as a potential anti-bacterial therapeutic agent. Bacteria are very complex organisms and I look forward to sharing our experiences with the company's scientific team."
"We are very pleased to welcome Dr. Kaplan," said Dr. Malcolm Skolnick, CytoGenix Chairman and CEO. "Sam is an outstanding scientist and an excellent person. We are very fortunate to continue to attract persons of his caliber to be associated with our company.
"Our Scientific Advisory Board is an invaluable resource as we move forward in the applying our technology to human health products," adds Dr. Skolnick.
CytoGenix Inc. is a biopharmaceutical company that develops and markets innovative products and services based on its proprietary DNA expression technology. CytoGenix has products in pre-clinical development, including anti-herpes, anti-psoriasis and anti-inflammatory topical creams. The company owns a US patent for its DNA expression technology and has 40 international or US patent applications.
SAFE HARBOR: Except for statements of historical fact, the statements in this press release are forward-looking. Such statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from the statements made. These factors include, but are not limited to, general economic conditions, risks associated with the acceptance of new products, competition, and other factors more fully detailed in the company's filings with the Securities and Exchange Commission. Additional information about CytoGenix and its technology can be found on the Web site at www.cytogenix.com.
--------------------------------------------------------------------------------
Contact:
CytoGenix Inc.
Juan Ferreira, 407-774-9949
mainhiker.....First you don't like chipped's pumpkins, then you pick on his turkey, but picking on Calvin and Hobbs is going to far. You must be real fun at a party, lighten up.;)
Happy Thanksgiving to all,
Rick
yayaa google toolbar has a pop-up blocker that works great and you can search from any page
Thanks thalio...
Keep up the great posts, and looking forward to your report.
Rick
Press Release Source: MoneyTV; International Monetary Systems, Ltd.; PracticeXpert, Inc.; Cytogenix Inc.; Semotus Solutions, Inc.
MoneyTV, Week of 11/7
Friday November 7, 10:00 am ET
LOS ANGELES, Nov. 07, 2003 (PRIMEZONE) -- MoneyTV is the nationally syndicated television program all about money and what makes it happen, (http://www.moneytv.net), featuring informative interviews with CEOs, insights into their operations and outlooks for their futures.
Free information packages from the featured companies can be requested by sending an email to info@moneytv.net.
The television program can also be viewed online immediately at http://www.moneytv.net.
Featured companies on this week's show include:
International Monetary Systems, Ltd. (OTC BB:INLM.OB - News) CEO Don Mardak explained his company's barter and trade business and announced the recent month had been the best in the company's history.
PracticeXpert, Inc. (OTC BB:PXPT.OB - News) CFO Michael Manahan announced the closing of a recent acquisition.
Cytogenix Inc. (OTC BB:CYGX.OB - News) CEO Dr. Malcolm Skolnick detailed further insight into the company's gene silencing research.
Semotus Solutions, Inc. (AMEX:DLK - News) CEO Anthony Lapine announced the release of the company's most recent filings and declared the company has moved even closer to profitability.
RBC Dain Rauscher Senior Vice-President Irwin Shapiro provided information about the latest buying opportunities in the bond markets.
Susan Dumeyer reported on the week's activities at the American Stock Exchange; Jack Bouroudjian analyzed the market from the Chicago Mercantile Exchange.
Viewers of MoneyTV can receive free information in the mail about featured companies by calling the toll-free phone number on their TV screen. The weekly television program debuted in 1996 and is broadcast nationally on Fridays at 11:30AM and 5:00PM ET, Saturdays at 1:30PM ET, Sundays at 6:30 AM PT, 8:00 AM ET and 11:00 AM ET, 8:00 AM PT and Thursdays at 6:30 AM ET.
MoneyTV is also broadcast as a radio program in several key East Coast markets.
A complete menu of TV and Radio listings is available at the MoneyTV web site, http://www.moneytv.net
MoneyTV television program, Copyright MMIII, all rights reserved. MoneyTV does not provide an analysis of companies' financial positions and is not soliciting to purchase or sell securities of the companies, nor are we offering a recommendation of featured companies or their stocks. Information discussed herein has been provided by the companies and should be verified independently with the companies and a securities analyst. MoneyTV provides companies a 3 to 4 month corporate profile with multiple appearances for a cash fee of $11,500.00 to $17,250.00, does not accept company stock as payment for services, does not hold any positions, options or warrants in featured companies. The information herein is not an endorsement by the producers, publisher or parent company of MoneyTV.
Contact:
MoneyTV
Donald Baillargeon
(310) 265-2223
info@moneytv.net
--------------------------------------------------------------------------------
Source: MoneyTV; International Monetary Systems, Ltd.; PracticeXpert, Inc.; Cytogenix Inc.; Semotus Solutions, Inc.
RE Crashing systems...
If you go to tools..settings...you can turn off embedded sounds and also graphics.
I don't dislike the tunes but sometimes they wake the little ones.
OA.....and anyone else having problems,
what operating system are you using?
windows xp, 2000, 98, 95 or other
Rick
OT I hope they don't rush this cure
http://www.theillustrator.com/CNN.com-StudyNewstudyshows.htm
No offense intended
Peach still didn't work, how about a cut and paste.
Rick
OT: I give permission for a wiggle, maybe you can find one on a cheerleaders sweater LOL.
Thanks chipped makes the poetry more enjoyable;)